We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people wh... Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people who are suffering from fibromyalgia. Show more
ATLANTA, May 22, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company” or “Virios Therapeutics”), a development-stage biotechnology company focused on advancing novel...
ATLANTA, May 19, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company” or “Virios Therapeutics”), a development-stage biotechnology company focused on advancing novel...
ATLANTA, May 17, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company” or “Virios Therapeutics”), a development-stage biotechnology company focused on advancing novel...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.2119 | -54.0285568587 | 0.3922 | 0.42 | 0.1557 | 1644981 | 0.21403715 | CS |
4 | -0.2575 | -58.8168113294 | 0.4378 | 0.4749 | 0.1557 | 496314 | 0.24549316 | CS |
12 | -0.2087 | -53.6503856041 | 0.389 | 0.6288 | 0.1557 | 431668 | 0.36503099 | CS |
26 | -0.4997 | -73.4852941176 | 0.68 | 0.94 | 0.1557 | 330708 | 0.42818566 | CS |
52 | -0.9197 | -83.6090909091 | 1.1 | 2.42 | 0.1557 | 483396 | 1.01079497 | CS |
156 | -5.5697 | -96.8643478261 | 5.75 | 9.1109 | 0.1557 | 501615 | 1.00483512 | CS |
260 | -13.5797 | -98.6896802326 | 13.76 | 14.39 | 0.1557 | 475654 | 1.54121694 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions